Understanding Cancer Treatment Experiences in Texas
This study is looking for Texas residents aged 18 and older who have been diagnosed with breast, colorectal, lung, or prostate cancer. The goal is to understand what helps and what makes it difficult to get timely cancer treatment. You would share your experiences through a 30-45 minute phone interview or a 45-60 minute video conference focus group. Researchers want to identify common challenges and helpful factors across different types of cancer and insurance. The study plans to enroll 120 participants and is currently unclear about its recruitment status. The main thing researchers will be looking at is safety and any side effects throughout the study, which is expected to last about one year.
- Study design
- This study is an interventional study that aims to enroll 120 participants. It uses interviews and focus groups to gather information.
- What's involved
- You would participate in either a 30-45 minute phone interview or a 45-60 minute video conference focus group.
- Compensation
- Not stated in the trial record.
- Follow-up
- Safety and adverse events will be measured through study completion, which is an average of 1 year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Facilitators and Barriers to Cancer Treatment Among Texas Residents
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- John Lin, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- 1. Safety and Adverse Events (AEs)Through study completion; an average of 1 year
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0